Diebold Nixdorf Incorporated Common stock (DBD)
Industrials › Calculating & Accounting Machines (No Electronic Computers)
Price History
Feb 9, 2026 — May 20, 2026Investment Snapshot
- Trading 122% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- ROE of 4.9% — below-average profitability
Diebold Nixdorf Incorporated Common stock (DBD) is a Industrials company operating in Calculating & Accounting Machines (No Electronic Computers), listed on the NYSE , with a market capitalisation of $2.4 billion . Key value metrics: P/E ratio 47.6, P/B ratio 2.33, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Diebold Nixdorf Incorporated Common stock — Fundamental Analysis Summary
Diebold Nixdorf Incorporated Common stock (DBD) is currently trading 122% above its Graham Number of $30.98, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 47.6x.
On financial health, DBD shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 4.9% (sector average: 4.9%), and manageable leverage with a debt-to-equity ratio of 0.92.
StockPik's composite Value Score for DBD is 72/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
DBD reports a moderate gross margin of 24.9% (sector average: 46.3%) and a modest operating margin of 5.4%.
DBD shows revenue growing at 1% year-over-year, with earnings growing at 673%.